We've moved! Same resources, new address:

Find resources

Total results with these characteristics: 162

Topic: Immunization financing

Page 7 of 9
Pull Mechanisms for Value-Added Technologies for Vaccines

Project Optimize, a collaboration between PATH and the World Health Organization, commissioned this white paper to examine the issues influencing vaccine producer willingness to advance, adopt, and commercialize value-added technologies for …

Author: PATH, World Health Organization

Publication date: 2009

R&D for Diarrhoeal Diseases

While preventive measures such as clean drinking water and sanitation can reduce the risk of infection from diarrheal diseases, research and development (R&D) of new tools is equally important, particularly for vaccines as they can prevent …

Author: Policy Cures

Publication date: 2013

Reduced Price on Rotavirus Vaccines: Enough to Facilitate Access Where Most Needed?

This article, published in the Bulletin of the World Health Organization, examines whether the reduced prices for rotavirus vaccine are affordable enough to facilitate access to the vaccine where it is most needed. The study points to the rotavirus …

Author: Madsen LB, Ustrup M, Fischer TK, Bygbjerg IC, Konradsen F

Publication date: 2012

Refocusing Gavi for Greater Impact

This report outlines the large impact that Gavi, the Vaccine Alliance, has had on immunization rates in eligible countries through funding support and dispersal of vaccines. It also provides recommendations on how Gavi could have a greater impact. …

Author: Dykstra S, Glassman A, Kenny C, Sandefur J (Center for Global Development)

Publication date: 2015

Resources: From pneumoACTION to Now

This web page offers a vast array of links to resources on a leading cause of child morbidity and mortality, pneumococcal diseases. It provides information on available vaccines, vaccine safety, disease burden, immunization financing, and other …

Author: International Vaccine Access Center

Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries

This article, published in PLoS ONE, discusses the estimated economic impact of implementing comprehensive human papillomavirus (HPV) screening and prevention programs in low- and middle-income countries. The authors performed a modeling analysis …

Author: Campos NG, Sharma M, Clark A, Kim JJ, Resch SC

Publication date: 2016

Revised Procedure for WHO Prequalification of Vaccines

This web page provides an explanation and link to the revised procedure for assessing the acceptability of vaccines in order to verify that they meet the specifications of the relevant United Nations agency for procurement and that they are produced …

Author: World Health Organization

Publication date: 2013

RHO Cervical Cancer Library

This website is designed to provide easy access to science-based information for health program managers and decision-makers seeking to prevent cervical cancer in developing countries and low-resource settings. The wide range of materials appearing …

Author: PATH

The Right Shot: Bringing Down Barriers to Affordable and Adapted Vaccines - 2nd Edition

This second edition of The Right Shot gathers more than 1,500 data points from organizations including UNICEF, the Pan-American Health Organization, governments, vaccine manufacturers, and Médecins Sans Frontières' supply centers to better …

Author: Médecins Sans Frontières

Publication date: 2015

The Right Shot: Extending the Reach of Affordable and Adapted Vaccines

Lack of information on both the price and the different product characteristics of vaccines limits countries’ ability to operate affordable and effective immunization programs. This report aims to remedy some of the existing knowledge gaps by …

Author: Médecins Sans Frontières

Publication date: 2012

Roadmap for Implementing the Addis Declaration on Immunization: Advocacy, Action, and Accountability

In January 2017, Heads of State from across Africa endorsed the Addis Declaration on Immunization (ADI), a historic pledge to ensure that everyone in Africa receives the full benefits of Immunization. This report provides a roadmap for countries in …

Author: African Member States, World Health Organization, African Union Commission

Publication date: 2017

Rotavirus Disease in Uzbekistan: Cost-Effectiveness of a New Vaccine

Investigators estimated the costs related to rotavirus disease in Uzbekistan and determined that a vaccine would be cost-effective, while also drastically reducing hospitalizations and deaths. This article was published in the journal Vaccine.

Author: Isakbaeva E, Musabaevc E, Antil L, et al.

Publication date: 2007

Rotavirus in Asia: Updates on Disease Burden, Genotypes, and Vaccine Introduction

This special edition of the journal Vaccine broadens understanding of rotavirus disease burden, which is responsible for almost half of acute diarrhea hospitalizations among Asian children under five. In addition to documenting rotavirus …

Author: Nelson AS, Widdowson MA, Kilgore PE, Steele D, Parashar U, eds.

Publication date: 2009

Rotavirus in India: An Update on Epidemiology and Vaccines

This supplemental issue of Vaccine features 25 original research articles on rotavirus in India. It covers a variety of topics in relation to rotavirus and specific to India, including updates on disease burden and surveillance activities, …

Author: Tate JE, Arora R, Bhan MK, Yewale V, Parashar UD, Kang G, eds.

Publication date: 2014

Rotavirus Vaccination: Cost-Effectiveness and Impact on Child Mortality in Developing Countries

This article, published in The Journal of Infectious Diseases, aimed to project the uptake, health impact, and cost-effectiveness of introducing rotavirus vaccination in GAVI-eligible countries. The authors used a demand forecast model to predict …

Author: Atherly D, Dreibelbis R, Parashar UD, Levin C, Wecker J, Rheingans RD

Publication date: 2009

Rotavirus Vaccine RIX4414 (Rotarix™): A Pharmacoeconomic Review of its Use in the Prevention of Rotavirus Gastroenteritis in Developing Countries

This article, published in Pharmacoeconomics, provides an overview of the clinical profile of rotavirus vaccine RIX4414 (Rotarix™) in the prevention of rotavirus gastroenteritis in developing countries, followed by a comprehensive review of …

Author: Plosker GL

Publication date: 2011

RSV Vaccine Use – The Missing Data

This article, published in Expert Review of Vaccines, explains the need for more data and knowledge on respiratory syncytial virus (RSV) epidemiology in different settings and age groups, as well as virus transmission and healthcare costs of the …

Author: Drysdale SB, Sande CJ, Green CA, Pollard AJ

Publication date: 2016

Some Vaccine Costs Are Hidden Below the Surface

This banner serves as the backdrop for a vaccine presentation game in the project Optimize traveling exhibit—an exhibit featuring supply chain innovations being developed and tested in different countries around the world. The banner …

Author: PATH, World Health Organization

Publication date: 2013

State of the World's Vaccines and Immunization, Third Edition

This report focuses on the major developments in vaccines and immunization since 2000. Part 1 examines the impact of immunization on efforts to meet the Millennium Development Goals. It looks at the development and use of vaccines and the …

Author: World Health Organization, United Nations Children's Fund, World Bank

Publication date: 2009

Staying the Course? Malaria Research and Development in a Time of Economic Uncertainty

This technical report from the Roll Back Malaria Partnership and partners shines a spotlight on recent trends in investments in malaria research and development (R&D). The report follows up on a 2005 study by the Malaria R&D Alliance to …

Author: PATH

Publication date: 2011

Page 7 of 9